From the ∗Urogynecology Unit, Department of Obstetrics and Gynecology, Hadera, Israel

†Inova Women’s Hospital, Fairfax, VA

‡New York City Health & Hospitals–Lincoln, New York, NY

§Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

∥MedStar Washington Hospital Center and Georgetown University School of Medicine, Washington, DC

¶Kaiser Permanente Northwest, Portland, OR

∗∗Stanford University School of Medicine, Stanford, CA

††Medical College of Thomas Jefferson University, The Institute for Female Pelvic Medicine & Reconstructive Surgery, North Wales, PA

‡‡University of Arizona-Phoenix COM, Phoenix, AZ

§§Kimble Center, Beverly Hills, CA

∥∥Department of Obstetrics and Gynecology, The University of Virginia Inova Campus, Inova Women’s Hospital, Fairfax, VA.

Correspondence: S. Abbas Shobeiri, MD, MBA. E-mail: [email protected].

A.C. received Pfizer institutional grant for menopause education and created legal reviews for Ethicon. B.G. is a co-investigator at a multicenter genitourinary syndrome of menopause trial with Sciton’s Diva Laser and declares no industry conflicts. C.B.I. is a co-investigator at a multicenter clinical trial for lasers and declares industry conflicts. M.M. is part of the speakers’ bureau for AMAG Pharmaceuticals. E.R.S. is the principal investigator for Food and Drug Administration submission for Mona Lisa, and declares no direct funding but grant funding to university.

The other authors have declared they have no conflicts of interest.